{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-001346","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.750223+00:00","generated_at":"2026-05-31T08:02:22.571152+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lexaria Bioscience enters $20M at-the-market equity sales agreement with JonesTrading","bullets":["Up to $20M of common stock may be sold from time to time through Agent JonesTrading as ATM offering.","Agent will receive 3.0% commission on gross sales price; Company reimburses certain expenses.","Shares sold under previously effective shelf registration statement (File No. 333-262402).","Agreement terminates upon sale of all Shares or earlier termination by either party.","No assurance any Shares will be issued; proceeds used for general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-001346","json":"https://secwatch.observer/filing/0001640334-24-001346.json","markdown":"https://secwatch.observer/filing/0001640334-24-001346.md","text":"https://secwatch.observer/filing/0001640334-24-001346.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/0001640334-24-001346-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033424001346/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:02:22.571152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}